CF Industries shares fell 1.4% to $116.45 on Aug. 5. The latest report, filed the following day, describes a business that made far more money in the three months ended June 30: revenue rose 17.6% to $2.2 billion, while operating income climbed 73.0% to $1.1 billion.
That is a sharp improvement in operating leverage, the plain-English measure of how much profit arrives with each additional dollar of sales. Operating margin rose to 50.5% from 34.3%. Diluted EPS nearly doubled to $4.73, helped by a 5.6% reduction in diluted shares.
The less tidy detail is on the balance sheet. Inventory rose 31.3% to $415 million, faster than revenue, and accounts receivable increased 22.5% to $718 million. The business generated more earnings, but more of its sales and production were sitting in working capital at the period end.
CF also spent more. Capital spending rose 31.0% year over year, and free-cash-flow margin declined by 0.8 percentage points even as operating income surged. The company does not disclose a cause for the inventory or receivables increases in the supplied filing facts, so the numbers are an exposure to track rather than an explanation by themselves.
The profit improvement was concentrated in the income statement. Gross profit increased 51.7%, taking gross margin to 51.5% from 39.9%. That is the strongest current receipt for the business itself: revenue grew by less than one-fifth, but the gross profit line grew by more than half.
The other important receipt is a reminder that this margin profile sits inside a commodity-linked business, not a subscription software company. CF pointed readers back to its annual risk discussion:
"See Item 7A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 for information on our market risk exposure due to changes in commodity prices, interest rates and foreign currency exchange rates, and our utilization of natural gas derivatives and an analysis of the sensitivity of these derivatives."
CF Industries, Form 10-Q, Aug. 6, 2026
In other words, the three-month numbers show unusually strong profitability, while the company is still exposed to prices for the inputs and products that shape that profitability. The latest 10-Q points readers to the sensitivity analysis rather than supplying a new quantified market-risk measure in the facts provided.
CF's annual results add some history without resolving the current tension. Revenue recovered 19.3% in 2025 to $7.1 billion after falling 40.7% in 2023 and another 10.5% in 2024. Operating margin also rose to 32.5% last year from 29.4%, but the current three-month margin is materially higher than that recent annual figure.
CF's next quarterly report will put the open loop in one place: whether inventory and accounts receivable continue to grow faster than revenue, alongside the cash-flow effect of the higher capital spending. For now, the filing offers a simple trade-off with an accounting footnote attached: more profit per sale, more business parked on the balance sheet.